Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.

Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW.

Liver Transpl. 2003 Oct;9(10):1053-61.

2.

Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.

Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Kelley M, Bozorgzadeh A.

Transplant Proc. 2005 Sep;37(7):3187-9.

PMID:
16213345
3.

Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.

Skagen CL, Jou JH, Said A.

Clin Transplant. 2011 May-Jun;25(3):E243-9. doi: 10.1111/j.1399-0012.2011.01409.x. Epub 2011 Feb 16.

PMID:
21323735
4.

Donor pool expansion in liver transplantation.

Montalti R, Nardo B, Bertelli R, Beltempo P, Puviani L, Vivarelli M, Cavallari A.

Transplant Proc. 2004 Apr;36(3):520-2.

PMID:
15110578
5.

Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.

Tandoi F, Romagnoli R, Martini S, Mazza E, Nada E, Cocchis D, Lupo F, Salizzoni M.

Transplant Proc. 2012 Sep;44(7):1960-2. doi: 10.1016/j.transproceed.2012.07.061.

PMID:
22974882
6.

Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.

Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.

Clin Transplant. 2011 Jan-Feb;25(1):E77-81. doi: 10.1111/j.1399-0012.2010.01329.x. Epub 2010 Oct 11.

PMID:
21039887
7.

Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.

Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.

Hepatobiliary Pancreat Dis Int. 2004 Feb;3(1):26-32.

8.

Safe use of livers from donors with positive hepatitis B core antibody.

Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ.

Liver Transpl. 2002 Jun;8(6):556-61.

9.

Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.

Loinaz C, Lumbreras C, Moreno E, Colina F, Fuertes A, Gómez R, Jiménez C, González-Pinto I, García I, Rojas J, Bellorín C.

Hepatogastroenterology. 2001 Sep-Oct;48(41):1435-42.

PMID:
11677981
10.

Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.

Veroux M, Puliatti C, Gagliano M, Cappello D, Macarone M, Vizcarra D, Spataro M, Di Mare M, Ginevra N, Veroux P.

Transplant Proc. 2005 Jul-Aug;37(6):2574-5.

PMID:
16182748
11.

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts.

Vargas HE, Laskus T, Wang LF, Lee R, Radkowski M, Dodson F, Fung JJ, Rakela J.

Gastroenterology. 1999 Jul;117(1):149-53.

PMID:
10381921
12.

Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.

Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.

Liver Transpl. 2006 Oct;12(10):1496-503.

13.

Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation.

Duhart BT Jr, Honaker MR, Shokouh-Amiri MH, Riely CA, Vera SR, Taylor SL, Al-jedai AH, Gaber AO.

Transpl Infect Dis. 2003 Sep;5(3):126-31.

PMID:
14617300
14.

Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.

Veroux M, Corona D, Ekser B, Giaquinta A, Tallarita T, De Martino C, Gentile F, Virgilio C, Gagliano M, Fiamingo P, Veroux P.

Transplant Proc. 2011 May;43(4):967-70. doi: 10.1016/j.transproceed.2011.01.155.

PMID:
21620027
15.

Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection.

Ghabril M, Dickson RC, Krishna M, Bonatti H, Aranda-Michel J, Keaveny AP, Satyanarayana R, Hewitt W, Hughes CB, Nguyen JH.

Transplantation. 2009 Apr 27;87(8):1174-9. doi: 10.1097/TP.0b013e31819ea72f.

PMID:
19384164
16.

Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.

Bizollon T, Ahmed SN, Guichard S, Chevallier P, Adham M, Ducerf C, Baulieux J, Trepo C.

Gut. 2000 Nov;47(5):698-702.

17.

The outcome of liver grafts procured from hepatitis C-positive donors.

Velidedeoglu E, Desai NM, Campos L, Olthoff KM, Shaked A, Nunes F, Zeldin G, Stewart C, Blumberg E, Abrams J, Markmann JF.

Transplantation. 2002 Feb 27;73(4):582-7.

PMID:
11889435
18.

Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis.

Saab S, Ghobrial RM, Ibrahim AB, Kunder G, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Busuttil RW.

Am J Transplant. 2003 Sep;3(9):1167-72.

19.

Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants.

Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, Kiuchi T, Miyake Y, Tanaka K, Chiba T.

Transplantation. 1998 Feb 27;65(4):494-9.

PMID:
9500622
20.

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.

Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators.

J Hepatol. 2013 Apr;58(4):715-23. doi: 10.1016/j.jhep.2012.11.025. Epub 2012 Nov 28.

PMID:
23201239

Supplemental Content

Support Center